iSpecimen (ISPC) Equity Ratio (2020 - 2026)

iSpecimen's Equity Ratio history runs 7 years deep, the most recent figure standing at 0.12 for Q1 2026.

• In Q1 2026, Equity Ratio fell 49.49% year-over-year to 0.12; the TTM figure through Mar 2026 stood at 0.12 (down 49.49% YoY), while the FY2025 annual figure was 0.32, down 8.5% from the prior year.
• Equity Ratio was 0.12 for Q1 2026 at iSpecimen, down from 0.32 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.84 in Q2 2023 to a low of 0.1 in Q2 2025.
• Historically, Equity Ratio has averaged 0.55 across 5 years, with a median of 0.54 in 2024.
• The sharpest annual moves came in 2022 and 2025: Equity Ratio soared 52.78% in 2022, then plunged 79.85% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.82 in 2022, then slipped by 25.36% to 0.62 in 2023, then plunged by 42.49% to 0.35 in 2024, then retreated by 8.5% to 0.32 in 2025, then plunged by 61.99% to 0.12 in 2026.
• The last three Equity Ratio figures came in at 0.12 (Q1 2026), 0.32 (Q4 2025), and 0.34 (Q3 2025), per Business Quant data.